122 - Re-purposing nonantibiotic therapeutics for multidrug-resistant pathogens

Speaker(s)

• SD

  Sara Dann, PhD

  Assistant Professor
  University of Texas Medical Branch
  Galveston, TX

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Dmitri Iarikov, MD, PhD

  Deputy Director, Division of Anti-Infectives
  FDA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-464-H01-P

Learning Objectives:

• discuss potential alternatives to traditional therapies for bacterial infections
• discuss the safety and efficacy concerns of nonantibiotic therapeutics in clinical practice

Presentations:

• 10:00am – 11:15am EDT

  Re-purposing Nonantimicrobial Therapeutics for Multidrug-resistant Pathogens; FDA Perspective
  Dmitri Iarikov, MD, PhD – FDA
• 10:00am – 11:15am EDT

  Scientific Basis of Nonantibiotic Therapeutics
  Sara Dann, PhD – University of Texas Medical Branch